Long-term effectiveness of the trabecular micro-bypass (iStent): 3-year real world data in glaucoma and ocular hypertension
This large, real-world cohort demonstrates a significant and sustained IOP reduction with an improvement in medication burden 3 years after iStent inject® and phacoemulsification. An excellent safety profile was displayed with a low rate of further glaucoma surgery required.
Authors
- M. Abu-Bakra
- Gerassimos Lascaratos (ORCID: https://orcid.org/0000-0001-5936-1431)
- Cristina Ginés-Gallego (ORCID: https://orcid.org/0000-0001-9256-8039)
- Sara Issa (ORCID: https://orcid.org/0000-0001-6725-3860)
- Sameer Trikha (ORCID: https://orcid.org/0000-0002-9446-496X)
- Ujjwal Banerjee
- Obeda Kailani (ORCID: https://orcid.org/0000-0002-6623-1720)
- Stafford Sansome
- Benjamin Griffin (ORCID: https://orcid.org/0000-0002-6067-8417)
- Avi Kulkarni
- Marianne Pavel
Institutions
- King's College London (GB)
- Wellcome Sanger Institute (GB)
- Al-Balqa Applied University (JO)
- King's College Hospital NHS Foundation Trust (GB)
Publication Details
- Journal
- International Ophthalmology
- Published
- 2025-11-24
- DOI
- https://doi.org/10.1007/s10792-025-03848-0
- Primary Topic
- Glaucoma and retinal disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00